Microscopic observations of the different morphological changes caused by anti-bacterial peptides on Klebsiella pneumoniae and HL-60 leukemia cells
- PMID: 9851369
- DOI: 10.1002/(SICI)1099-1387(199811)4:7%3C413::AID-PSC160%3E3.0.CO;2-W
Microscopic observations of the different morphological changes caused by anti-bacterial peptides on Klebsiella pneumoniae and HL-60 leukemia cells
Abstract
Natural anti-bacterial peptides cecropin B (CB) and its analogs cecropin B-1 (CB-1), cecropin B-2 (CB-2) and cecropin B-3 (CB-3) were prepared. The different characteristics of these peptides, with amphipathic/hydrophobic alpha-helices for CB, amphipathic/amphipathic alpha-helices for CB-1/CB-2, and hydrophobic/hydrophobic alpha-helices for CB-3, were used to study the morphological changes in the bacterial cell, Klebsiella pneumoniae and the leukemia cancer cell, HL-60, by scanning and transmission electron microscopies. The natural and analog peptides have comparable secondary structures as shown by circular dichroism measurements. This indicates that the potency of the peptides on cell membranes is dependent of the helical characteristics rather than the helical strength. The microscopic results show that the morphological changes of the cells treated with CB are distinguishably different from those treated with CB-1/CB-2, which are designed to have enhanced anti-cancer properties by having an extra amphipathic alpha-helix. The morphological differences may be due to their different modes of action on the cell membranes resulting in the different potencies with lower lethal concentration and higher concentration of 50% inhibition (IC50) of CB on bacterium and cancer cell, respectively, as compared with CB-1/:CB-2 (Chen et al. 1997. Biochim. Biophys. Acta 1336, 171-179). In contrast, CB-3 has little effect on either the bacterium or the cancer cell. These results provide microscopic evidence that different killing pathways are involved with the peptides.
Similar articles
-
Effects of the anti-bacterial peptide cecropin B and its analogs, cecropins B-1 and B-2, on liposomes, bacteria, and cancer cells.Biochim Biophys Acta. 1997 Aug 29;1336(2):171-9. doi: 10.1016/s0304-4165(97)00024-x. Biochim Biophys Acta. 1997. PMID: 9305787
-
Distinguishing between different pathways of bilayer disruption by the related antimicrobial peptides cecropin B, B1 and B3.Eur J Biochem. 2003 Mar;270(5):911-20. doi: 10.1046/j.1432-1033.2003.03451.x. Eur J Biochem. 2003. PMID: 12603324
-
The dependence of membrane permeability by the antibacterial peptide cecropin B and its analogs, CB-1 and CB-3, on liposomes of different composition.J Biol Chem. 1998 Oct 16;273(42):27438-48. doi: 10.1074/jbc.273.42.27438. J Biol Chem. 1998. PMID: 9765273
-
Comparative mode of action of novel hybrid peptide CS-1a and its rearranged amphipathic analogue CS-2a.FEBS J. 2012 Oct;279(20):3776-90. doi: 10.1111/j.1742-4658.2012.08738.x. Epub 2012 Sep 7. FEBS J. 2012. PMID: 22883393
-
Antibacterial peptides isolated from insects.J Pept Sci. 2000 Oct;6(10):497-511. doi: 10.1002/1099-1387(200010)6:10<497::AID-PSC277>3.0.CO;2-W. J Pept Sci. 2000. PMID: 11071264 Review.
Cited by
-
Tumor cell death mediated by peptides that recognize branched intermediates of DNA replication and repair.PLoS One. 2013 Nov 14;8(11):e78751. doi: 10.1371/journal.pone.0078751. eCollection 2013. PLoS One. 2013. PMID: 24244353 Free PMC article.
-
Cancer Wars: Revenge of the AMPs (Antimicrobial Peptides), a New Strategy against Colorectal Cancer.Toxins (Basel). 2023 Jul 14;15(7):459. doi: 10.3390/toxins15070459. Toxins (Basel). 2023. PMID: 37505728 Free PMC article.
-
Studies on anticancer activities of antimicrobial peptides.Biochim Biophys Acta. 2008 Feb;1778(2):357-75. doi: 10.1016/j.bbamem.2007.11.008. Epub 2007 Nov 22. Biochim Biophys Acta. 2008. PMID: 18078805 Free PMC article. Review.
-
Unimolecular study of the interaction between the outer membrane protein OmpF from E. coli and an analogue of the HP(2-20) antimicrobial peptide.J Bioenerg Biomembr. 2010 Apr;42(2):173-80. doi: 10.1007/s10863-010-9273-z. Epub 2010 Feb 24. J Bioenerg Biomembr. 2010. PMID: 20180000
-
Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines.Probiotics Antimicrob Proteins. 2024 Jun;16(3):713-725. doi: 10.1007/s12602-023-10096-0. Epub 2023 Jun 9. Probiotics Antimicrob Proteins. 2024. PMID: 37294416
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical